Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP)

HZNP was delisted on the 5th of October, 2023.

• Market cap: $26.6B
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Employees: 2,190